The Drug Delivery Devices Market is projected to reach $24.65 billion by 2030, at a CAGR of 7.6% from 2023 to 2030. Drug delivery devices are storage systems or similar technologies that are used to administer drugs or medicines into the body of a patient through various routes in order to achieve a therapeutic effect.
The growth of the drug delivery devices market is driven by several factors, including the increasing prevalence of chronic diseases, the advancements in disease treatment approaches, growing R&D expenditure in pharmaceutical and biotechnology industries, and increasing demand for advanced drug delivery systems. Factors such as emerging economies and technological advancements in drug delivery systems are a few of the opportunities that would help grow the market in the future. Biocompatibility and acceptability could be considered a challenge for the drug delivery devices market. However, manufacturing defects and a lack of awareness and education about newer drug delivery systems restrain the growth of the market.
Chronic diseases, also known as non-communicable diseases, are disorders or conditions that are generally not caused due to an infection but by unhealthy habits or behaviors and also result in long-term health issues that require a long course of treatment. Some of the diseases included in this category are cardiovascular diseases, diabetes, chronic lung ailments, or even cancers. According to the World Health Organization (WHO), chronic diseases have been responsible for almost 74% of deaths across the world, growing due to risk factors, including the use of tobacco, unhealthy diets, physical inactivity, and inconsistent alcohol consumption.
Drug delivery systems have been considered to improve the therapeutic efficacy of targeted drugs, and also reduce systemic adverse effects, helping patients suffering from chronic diseases. As compared to conventional drugs, drug delivery using specific devices or systems also improves stability and compatibility, improved permeability, and precise targeting. For example, in the case of diseases such as Chronic Obstructive Pulmonary Disease (COPD), targeted delivery of drugs is being considered using inhalers as a delivery route due to quick absorption of the drug and faster onset of action.
The use of such drug delivery systems and devices helps achieve maximum pharmacological effects along with minimum side effects. The number of materials being used to deliver drugs has been increasing significantly and has shown great potential to treat chronic diseases, hence driving the growth of the market.
Click here to: Get Free Sample Pages of this Report
Technological Advancements in Drug Delivery Devices
Drug delivery devices are technologies or systems that store drug molecules and accelerate the reach of the drugs to various parts of the body depending on the disease that is being treated. This maximizes the therapeutic efficacy of the drug and minimizes its off-target accumulation in the body. In recent times, there have been a lot of changes and developments in order to provide a convenient, controlled, and targeted delivery of drugs. Furthermore, these changes have led to high efficacy and minimal off-target accumulation of the drug, therefore leading to the launches and approvals of several innovative products. For instance, in December 2022, Biocorp, a subsidiary of Novo Nordisk A/S (Denmark), announced the receival of the FDA 510(k) clearance to market Biocorp’s smart insulin pen device that automatically collects and records key treatment information and transmits it to a digital application. This data includes selected insulin units, date, and the time of injection.
Advanced drug delivery systems allow the patient to receive a tailored or specific amount of dose required, rapid, efficient, and sustained drug delivery, and minimize side effects of drugs. Advanced drug delivery systems and devices have proved to be useful for drug administration and are being suggested to be used as a carrier for novel drugs and also personalized treatment of patients based on the intensity and type of diagnosis or condition.
Several companies are aiming to develop new drug delivery systems in order to introduce new modalities of drugs. For instance, in April 2021, Gerresheimer AG (Germany) collaborated with SensAIR (Sweden) to present an on-body drug delivery device to help patients self-administer medication in a familiar environment such as their homes. This device can be used for drugs that have different viscosities and different requirements. This means that the size of the needle used and variable cartridge sizes can be adjusted through the patient’s smartphone.
Such developments aid the increase in the use of these technologies and increased patient compliance, hence leading to the growth of the market.
The Parenteral Drug Delivery Systems Segment is Expected to Account for the Largest Share of the Market in 2023
Among the products, in 2023, the parenteral drug delivery systems segment is expected to account for the largest share of the market. Parenteral drug delivery systems are an invasive type of route taken to administer drugs directly into the bloodstream without undergoing first-pass metabolism. This can be done through the subcutaneous route, intradermal route, intramuscular route, or intravenous route. Pen injectors, syringes, autoinjectors, wearable injectors, needle-free injectors, and transdermal patches are some of the devices that are used to administer drugs through this route. The large share of the market is driven by factors such as an effective route for delivering active pharmaceutical substances that may have less bioavailability, a narrow therapeutic index, and faster effectiveness to the required organ.
The Diabetes Segment is Expected to Account for the Largest Share of the Market in 2023
Among therapeutic areas, in 2023, the diabetes segment is expected to account for the largest share of the market. Diabetes is a non-communicable and chronic disease that occurs when the body is not able to produce sufficient insulin or cannot use the produced insulin to regulate the sugar a person consumes. Various drug delivery devices are used to regulate and track insulin levels in a patient. Some of these devices include insulin pumps, insulin pens, wearable glucose monitors, and autoinjectors, among others. These devices regulate and track insulin levels and are connected with an application whose access is with the healthcare provider and close family to monitor glucose levels and administer insulin whenever needed. This segment is driven by factors such as a large variety of available devices to manage insulin levels, improved patient drug compliance, and less risk of side effects due to uniform administration of drugs.
Key Players
The key players profiled in the drug delivery devices market report are Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), GMP Laboratories of America, Inc. (U.S.), Gemini Pharmaceuticals, Inc. (U.S.), Resyca GmbH (Netherlands), Novartis International AG (Switzerland), Becton, Dickinson, and Company (U.S.), Lifelong Meditech Private Limited (India), Bright Pharma Caps, Inc. (U.S.), Gerresheimer AG (Germany), West Pharmaceutical Services, Inc. (U.S.), Eclam Medical ACS Ltd. (Israel), SMC Ltd. (U.S.), Owen Mumford Limited (U.K.), Haselmeier GmbH (Germany), SHL Medical AG (Switzerland), Ypsomed Holding AG (Switzerland), AptarGroup, Inc. (U.S.), Kindeva Drug Delivery L.P. (U.S.), Nemera Group (France), and Recipharm AB (Sweden).
The report includes a competitive landscape based on an extensive assessment of the market based on the route of administration/formulation and therapeutic area. The report also provides insights into the presence of major market players and their key growth strategies in the last three to four years.
Summary Table:
|
Particular |
Details |
|
Page No |
~220 |
|
Format |
|
|
Forecast Period |
2023-2030 |
|
Base Year |
2022 |
|
CAGR |
7.6% |
|
Market Size (Value) |
$24.65 billion |
|
Market Size (Volume) |
NA |
|
Segments Covered |
Products and Therapeutic Area |
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Belgium, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, Indonesia, Singapore, Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America), Middle East & Africa (U.A.E., Saudi Arabia, South Africa, Rest of Middle East & Africa) |
|
Key Companies |
Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), GMP Laboratories of America, Inc. (U.S.), Gemini Pharmaceuticals, Inc. (U.S.), Resyca GmbH (Netherlands), Novartis International AG (Switzerland), Becton, Dickinson, and Company (U.S.), Lifelong Meditech Private Limited (India), Bright Pharma Caps, Inc. (U.S.), Gerresheimer AG (Germany), West Pharmaceutical Services, Inc. (U.S.), Eclam Medical ACS Ltd. (Israel), SMC Ltd. (U.S.), Owen Mumford Limited (U.K.), Haseleimer GmbH (Germany), SHL Medical AG (Switzerland), Ypsomed Holding AG (Switzerland), AptarGroup, Inc. (U.S.), Kindeva Drug Delivery L.P. (U.S.), Nemera Group (France), and Recipharm AB (Sweden), |
Scope of the Report:
Drug Delivery Devices Market, by Product
Drug Delivery Devices Market, by Therapeutic Area
Key questions answered in the report:
This market study covers the market sizes & forecasts of the drug delivery devices based on products, therapeutic areas, and geography. This market study also provides the value analysis of various segments and subsegments of the global drug delivery devices market at country levels.
The drug delivery devices market is projected to reach $24.65 billion by 2030, at a CAGR of 7.6% during the forecast period.
The parenteral drug delivery systems segment is expected to account for the largest share of the market in 2023. Factors such as the easy delivery of drugs at the subcutaneous, intradermal, intramuscular, and intravenous levels, fast-acting route of administration due to devices such as transdermal patches, syringes, autoinjectors, wearable injectors, among others, better biocompatibility and bioavailability, and precise drug dose delivery.
The diabetes segment is expected to account for the largest share of the drug delivery devices market. The growth of this segment is attributed to factors such as a large variety of devices available to manage insulin levels, such as wearable injectors, transdermal patches, insulin pens, and insulin pumps, among others, which improves the patient’s drug compliance, and reduced risk of side effects due to the uniform distribution of drugs.
The growth of the drug delivery devices market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in disease treatment approaches, growing R&D expenditure in pharmaceutical and biotechnology industries, and the increasing demand for advanced drug delivery systems.
Furthermore, emerging economies and technological advancements in drug delivery systems serve as major opportunities for the existing market players and new entrants in the drug delivery devices market.
The key players profiled in the drug delivery devices market report are Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), GMP Laboratories of America, Inc. (U.S.), Gemini Pharmaceuticals, Inc. (U.S.), Resyca GmbH (Netherlands), Novartis International AG (Switzerland), Becton, Dickinson, and Company (U.S.), Lifelong Meditech Private Limited (India), Bright Pharma Caps, Inc. (U.S.), Gerresheimer AG (Germany), West Pharmaceutical Services, Inc. (U.S.), Eclam Medical (Israel), SMC Ltd. (U.S.), Owen Mumford Limited (U.K.), Haselmeier GmbH (Germany), SHL Medical AG (Switzerland), Ypsomed Holding AG (Switzerland), AptarGroup, Inc. (U.S.), Kindeva Drug Delivery L.P. (U.S.), Nemera Group (France), and Recipharm AB (Sweden).
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increasing Prevalence of Chronic Diseases
4.2.2. Advancements in the Disease Treatment Approaches
4.2.3. Growing R&D Expenditure in Pharmaceutical and Biotechnology Industries
4.2.4. Increasing Demand for Advanced Drug Delivery Systems
4.3. Restraints
4.3.1. Manufacturing Defects
4.3.2. Lack of Awareness and Education About Newer Drug Delivery Systems
4.4. Opportunities
4.4.1. Emerging Economies
4.4.2. Technological Advancements in Drug Delivery Systems
4.5. Challenges
4.5.1. Biocompatibility And Acceptability
4.6. Trends
4.6.1. Use of Artificial Intelligence (AI) in Drug Delivery Systems
4.6.2. Evolution in the Connected Drug Delivery Devices
4.7. Regulatory Scenario
4.8. Pricing Analysis
4.9. Value Chain Analysis
5. Global Drug Delivery Devices Market—by Product
5.1. Overview
5.2. Nasal & Pulmonary Drug Delivery Systems
5.2.1. Nebulizers
5.2.1.1. Jet Nebulizers
5.2.1.2. Ultrasonic Nebulizers
5.2.1.3. Mesh Nebulizers
5.2.2. Empty Inhalers
5.2.2.1. Metered-Dose Inhalers
5.2.2.2. Soft Mist Inhalers
5.2.2.3. Dry Powder Inhalers
5.2.3. Steamers
5.2.4. Nasal Sprays
5.3. Parenteral Drug Delivery Systems
5.3.1. Syringes
5.3.1.1. Conventional Syringes
5.3.1.2. Safety Syringes
5.3.1.3. Prefilled Syringes
5.3.2. Pen Injectors
5.3.3. Autoinjectors
5.3.4. Needle-free Injectors
5.3.5. Wearable Injectors/ On-Body Drug Delivery System
5.4. Topical & Transdermal Drug Delivery Systems
5.4.1. Transdermal Patches
5.4.2. Wearable Patches
5.5. Drop Bottle Drug Delivery Systems
5.5.1. Nasal Drop Bottles
5.5.2. Ocular Drop Bottles
5.5.3. Cochlear Drop Bottles
5.6. Implantable Drug Delivery Devices
5.6.1. Inserts
5.6.2. Pumps
5.6.3. Drug Eluting Stents
5.7. Insulin Pumps
5.8. Intrauterine Devices
5.9. Infusion Pumps
6. Global Drug Delivery Devices Market—by Therapeutic Area
6.1. Overview
6.2. Diabetes
6.3. Infectious Diseases
6.4. Oncology
6.5. Cardiovascular Diseases
6.6. Respiratory Diseases
6.7. Neurological Disorders
6.8. Autoimmune Diseases
7. Drug Delivery Devices Market—by Geography
7.1. Overview
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Switzerland
7.3.7. Belgium
7.3.8. Rest of Europe
7.4. Asia-Pacific
7.4.1. Japan
7.4.2. China
7.4.3. India
7.4.4. Australia
7.4.5. South Korea
7.4.6. Indonesia
7.4.7. Singapore
7.4.8. Rest of Asia Pacific
7.5. Latin America
7.5.1. Brazil
7.5.2. Mexico
7.5.3. Rest of Latin America
7.6. Middle East & Africa
7.6.1. U.A.E.
7.6.2. Saudi Arabia
7.6.3. South Africa
7.6.4. Rest of Middle East & Africa
8. Competition Analysis
8.1. Overview
8.2. Key Growth Strategies
8.3. Competitive Benchmarking
8.4. Competitive Dashboard
8.4.1. Market Leaders
8.4.2. Market Differentiators
8.4.3. Vanguards
8.4.4. Emerging Companies
8.5. Market Share Analysis/ Market Ranking, By Key Players (2022)
9. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
9.1. Koninklijke Philips N.V.
9.2. OMRON Corporation
9.3. GMP Laboratories of America, Inc.
9.4. Gemini Pharmaceuticals, Inc.
9.5. Resyca GmbH
9.6. Novartis International AG
9.7. Becton, Dickinson and Company
9.8. Lifelong Meditech Private Limited
9.9. Bright Pharma Caps, Inc.
9.10. Gerresheimer AG
9.11. West Pharmaceutical Services, Inc.
9.12. Eclam Medical
9.13. SMC Ltd.
9.14. Owen Mumford Limited
9.15. Haselmeier GmbH
9.16. SHL Medical AG
9.17. Ypsomed Holding AG
9.18. AptarGroup, Inc.
9.19. Kindeva Drug Delivery L.P.
9.20. Nemera Group
9.21. Recipharm AB
9.22. Other Companies
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
10. Appendix
10.1. Available Customization
10.2. Related Reports
List of Tables
Table 1 Global Drug Delivery Devices Market: Impact Analysis of Market Drivers (2023–2030)
Table 2 Global Drug Delivery Devices Market: Impact Analysis of Market Restraints (2023–2030)
Table 3 Global Drug Delivery Devices Market: Impact Analysis of Market Opportunities (2023–2030)
Table 4 Global Drug Delivery Devices Market: Impact Analysis of Market Challenges (2023–2030)
Table 5 Global Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 6 Global Nasal & Pulmonary Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 7 Global Nasal & Pulmonary Drug Delivery Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 8 Global Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 9 Global Nebulizers Market, by Country/Region, 2021–2030 (USD Million)
Table 10 Global Jet Nebulizers Market, by Country/Region, 2021–2030 (USD Million)
Table 11 Global Ultrasonic Nebulizers Market, by Country/Region, 2021–2030 (USD Million)
Table 12 Global Mesh Nebulizers Market, by Country/Region, 2021–2030 (USD Million)
Table 13 Global Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 14 Global Empty Inhalers Market, by Country/Region, 2021–2030 (USD Million)
Table 15 Global Metered-dose Inhalers Market, by Country/Region, 2021–2030 (USD Million)
Table 16 Global Soft Mist Inhalers Market, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Dry Powder Inhalers Market, by Country/Region, 2021–2030 (USD Million)
Table 18 Global Steamers Market, by Country/Region, 2021–2030 (USD Million)
Table 19 Global Nasal Sprays Market, by Country/Region, 2021–2030 (USD Million)
Table 20 Global Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 21 Global Parenteral Drug Delivery Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 22 Global Syringes Market, by Type, 2021–2030 (USD Million)
Table 23 Global Syringes Market, by Country/Region, 2021–2030 (USD Million)
Table 24 Global Conventional Syringes Market, by Country/Region, 2021–2030 (USD Million)
Table 25 Global Safety Syringes Market, by Country/Region, 2021–2030 (USD Million)
Table 26 Global Prefilled Syringes Market, by Country/Region, 2021–2030 (USD Million)
Table 27 Global Pen Injectors Market, by Country/Region, 2021–2030 (USD Million)
Table 28 Global Autoinjectors Market, by Country/Region, 2021–2030 (USD Million)
Table 29 Global Needle Free Injectors Market, by Country/Region, 2021–2030 (USD Million)
Table 30 Global Wearable Injectors/On-body Drug Delivery Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 31 Global Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 32 Global Topical & Transdermal Drug Delivery Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 33 Global Transdermal Patches Market, by Country/Region, 2021–2030 (USD Million)
Table 34 Global Wearable Patches Market, by Country/Region, 2021–2030 (USD Million)
Table 35 Global Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 36 Global Drop Bottle Drug Delivery Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 37 Global Nasal Drop Bottles Market, by Country/Region, 2021–2030 (USD Million)
Table 38 Global Ocular Drop Bottles Market, by Country/Region, 2021–2030 (USD Million)
Table 39 Global Cochlear Drop Bottles Market, by Country/Region, 2021–2030 (USD Million)
Table 40 Global Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 41 Global Implantable Drug Delivery Devices Market, by Country/Region, 2021–2030 (USD Million)
Table 42 Global Implantable Inserts Market, by Country/Region, 2021–2030 (USD Million)
Table 43 Global Implantable Pumps Market, by Country/Region, 2021–2030 (USD Million)
Table 44 Global Implantable Drug Eluting Stents Market, by Country/Region, 2021–2030 (USD Million)
Table 45 Global Insulin Pumps Market, by Country/Region, 2021–2030 (USD Million)
Table 46 Global Intrauterine Devices Market, by Country/Region, 2021–2030 (USD Million)
Table 47 Global Infusion Pumps Market, by Country/Region, 2021–2030 (USD Million)
Table 48 Global Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 49 Global Drug Delivery Devices Market for Infectious Diseases, by Country/Region, 2021–2030 (USD Million)
Table 50 Global Drug Delivery Devices for Oncology, by Country/Region, 2021–2030 (USD Million)
Table 51 Global Drug Delivery Devices Market for Cardiovascular Diseases, by Country/Region, 2021–2030 (USD Million)
Table 52 Global Drug Delivery Devices Market for Respiratory Diseases, by Country/Region, 2021–2030 (USD Million)
Table 53 Global Drug Delivery Devices Market for Neurological Disorders, by Country/Region, 2021–2030 (USD Million)
Table 54 Global Drug Delivery Devices Market for Autoimmune Diseases, by Country/Region, 2021–2030 (USD Million)
Table 55 Global Drug Delivery Devices Market, by Country/Region, 2021–2030 (USD Million)
Table 56 North America: Drug Delivery Devices Market, by Country, 2021–2030 (USD Million)
Table 57 North America: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 58 North America: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 59 North America: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 60 North America: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 61 North America: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 62 North America: Syringes Market, by Type, 2021–2030 (USD Million)
Table 63 North America: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 64 North America: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 65 North America: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 66 North America: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 67 U.S.: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 68 U.S.: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 69 U.S.: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 70 U.S.: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 71 U.S.: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 72 U.S.: Syringes Market, by Type, 2021–2030 (USD Million)
Table 73 U.S.: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 74 U.S.: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 75 U.S.: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 76 U.S.: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 77 Canada: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 78 Canada: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 79 Canada: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 80 Canada: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 81 Canada: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 82 Canada: Syringes Market, by Type, 2021–2030 (USD Million)
Table 83 Canada: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 84 Canada: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 85 Canada: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 86 Canada: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 87 Europe: Drug Delivery Devices Market, by Country/Region, 2021–2030 (USD Million)
Table 88 Europe: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 89 Europe: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 90 Europe: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 91 Europe: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 92 Europe: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 93 Europe: Syringes Market, by Type, 2021–2030 (USD Million)
Table 94 Europe: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 95 Europe: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 96 Europe: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 97 Europe: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 98 Germany: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 99 Germany: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 100 Germany: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 101 Germany: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 102 Germany: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 103 Germany: Syringes Market, by Type, 2021–2030 (USD Million)
Table 104 Germany: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 105 Germany: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 106 Germany: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 107 Germany: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 108 France: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 109 France: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 110 France: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 111 France: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 112 France: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 113 France: Syringes Market, by Type, 2021–2030 (USD Million)
Table 114 France: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 115 France: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 116 France: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 117 France: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 118 U.K.: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 119 U.K.: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 120 U.K.: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 121 U.K.: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 122 U.K.: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 123 U.K.: Syringes Market, by Type, 2021–2030 (USD Million)
Table 124 U.K.: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 125 U.K.: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 126 U.K.: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 127 U.K.: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 128 Italy: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 129 Italy: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 130 Italy: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 131 Italy: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 132 Italy: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 133 Italy: Syringes Market, by Type, 2021–2030 (USD Million)
Table 134 Italy: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 135 Italy: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 136 Italy: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 137 Italy: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 138 Spain: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 139 Spain: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 140 Spain: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 141 Spain: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 142 Spain: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 143 Spain: Syringes Market, by Type, 2021–2030 (USD Million)
Table 144 Spain: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 145 Spain: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 146 Spain: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 147 Spain: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 148 Switzerland: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 149 Switzerland: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 150 Switzerland: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 151 Switzerland: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 152 Switzerland: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 153 Switzerland: Syringes Market, by Type, 2021–2030 (USD Million)
Table 154 Switzerland: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 155 Switzerland: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 156 Switzerland: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 157 Switzerland: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 158 Belgium: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 159 Belgium: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 160 Belgium: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 161 Belgium: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 162 Belgium: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 163 Belgium: Syringes Market, by Type, 2021–2030 (USD Million)
Table 164 Belgium: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 165 Belgium: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 166 Belgium: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 167 Belgium: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 168 Rest of Europe: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 169 Rest of Europe: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 170 Rest of Europe: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 171 Rest of Europe: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 172 Rest of Europe: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 173 Rest of Europe: Syringes Market, by Type, 2021–2030 (USD Million)
Table 174 Rest of Europe: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 175 Rest of Europe: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 176 Rest of Europe: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 177 Rest of Europe: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 178 Asia-Pacific: Drug Delivery Devices Market, by Country/Region, 2021–2030 (USD Million)
Table 179 Asia-Pacific: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 180 Asia-Pacific: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 181 Asia-Pacific: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 182 Asia-Pacific: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 183 Asia-Pacific: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 184 Asia-Pacific: Syringes Market, by Type, 2021–2030 (USD Million)
Table 185 Asia-Pacific: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 186 Asia-Pacific: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 187 Asia-Pacific: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 188 Asia-Pacific: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 189 China: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 190 China: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 191 China: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 192 China: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 193 China: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 194 China: Syringes Market, by Type, 2021–2030 (USD Million)
Table 195 China: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 196 China: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 197 China: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 198 China: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 199 Japan: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 200 Japan: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 201 Japan: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 202 Japan: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 203 Japan: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 204 Japan: Syringes Market, by Type, 2021–2030 (USD Million)
Table 205 Japan: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 206 Japan: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 207 Japan: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 208 Japan: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 209 India: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 210 India: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 211 India: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 212 India: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 213 India: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 214 India: Syringes Market, by Type, 2021–2030 (USD Million)
Table 215 India: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 216 India: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 217 India: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 218 India: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 219 Australia: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 220 Australia: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 221 Australia: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 222 Australia: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 223 Australia: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 224 Australia: Syringes Market, by Type, 2021–2030 (USD Million)
Table 225 Australia: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 226 Australia: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 227 Australia: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 228 Australia: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 229 South Korea: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 230 South Korea: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 231 South Korea: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 232 South Korea: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 233 South Korea: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 234 South Korea: Syringes Market, by Type, 2021–2030 (USD Million)
Table 235 South Korea: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 236 South Korea: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 237 South Korea: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 238 South Korea: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 239 Indonesia: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 240 Indonesia: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 241 Indonesia: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 242 Indonesia: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 243 Indonesia: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 244 Indonesia: Syringes Market, by Type, 2021–2030 (USD Million)
Table 245 Indonesia: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 246 Indonesia: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 247 Indonesia: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 248 Indonesia: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 249 Singapore: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 250 Singapore: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 251 Singapore: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 252 Singapore: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 253 Singapore: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 254 Singapore: Syringes Market, by Type, 2021–2030 (USD Million)
Table 255 Singapore: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 256 Singapore: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 257 Singapore: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 258 Singapore: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 259 Rest of Asia-Pacific: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 260 Rest of Asia-Pacific: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 261 Rest of Asia-Pacific: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 262 Rest of Asia-Pacific: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 263 Rest of Asia-Pacific: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 264 Rest of Asia-Pacific: Syringes Market, by Type, 2021–2030 (USD Million)
Table 265 Rest of Asia-Pacific: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 266 Rest of Asia-Pacific: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 267 Rest of Asia-Pacific: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 268 Rest of Asia-Pacific: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 269 Latin America: Drug Delivery Devices Market, by Country/Region, 2021–2030 (USD Million)
Table 270 Latin America: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 271 Latin America: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 272 Latin America: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 273 Latin America: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 274 Latin America: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 275 Latin America: Syringes Market, by Type, 2021–2030 (USD Million)
Table 276 Latin America: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 277 Latin America: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 278 Latin America: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 279 Latin America: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 280 Brazil: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 281 Brazil: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 282 Brazil: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 283 Brazil: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 284 Brazil: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 285 Brazil: Syringes Market, by Type, 2021–2030 (USD Million)
Table 286 Brazil: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 287 Brazil: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 288 Brazil: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 289 Brazil: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 290 Mexico: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 291 Mexico: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 292 Mexico: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 293 Mexico: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 294 Mexico: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 295 Mexico: Syringes Market, by Type, 2021–2030 (USD Million)
Table 296 Mexico: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 297 Mexico: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 298 Mexico: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 299 Mexico: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 300 Rest of Latin America: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 301 Rest of Latin America: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 302 Rest of Latin America: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 303 Rest of Latin America: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 304 Rest of Latin America: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 305 Rest of Latin America: Syringes Market, by Type, 2021–2030 (USD Million)
Table 306 Rest of Latin America: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 307 Rest of Latin America: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 308 Rest of Latin America: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 309 Rest of Latin America: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 310 Middle East & Africa: Drug Delivery Devices Market, by Country/Region, 2021–2030 (USD Million)
Table 311 Middle East & Africa: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 312 Middle East & Africa: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 313 Middle East & Africa: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 314 Middle East & Africa: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 315 Middle East & Africa: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 316 Middle East & Africa: Syringes Market, by Type, 2021–2030 (USD Million)
Table 317 Middle East & Africa: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 318 Middle East & Africa: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 319 Middle East & Africa: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 320 Middle East & Africa: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 321 U.A.E.: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 322 U.A.E.: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 323 U.A.E.: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 324 U.A.E.: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 325 U.A.E.: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 326 U.A.E.: Syringes Market, by Type, 2021–2030 (USD Million)
Table 327 U.A.E.: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 328 U.A.E.: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 329 U.A.E.: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 330 U.A.E.: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 331 Saudi Arabia: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 332 Saudi Arabia: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 333 Saudi Arabia: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 334 Saudi Arabia: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 335 Saudi Arabia: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 336 Saudi Arabia: Syringes Market, by Type, 2021–2030 (USD Million)
Table 337 Saudi Arabia: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 338 Saudi Arabia: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 339 Saudi Arabia: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 340 Saudi Arabia: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 341 South Africa: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 342 South Africa: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 343 South Africa: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 344 South Africa: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 345 South Africa: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 346 South Africa: Syringes Market, by Type, 2021–2030 (USD Million)
Table 347 South Africa: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 348 South Africa: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 349 South Africa: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 350 South Africa: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
Table 351 Rest of Middle East & Africa: Drug Delivery Devices Market, by Route of Administration/Formulation, 2021–2030 (USD Million)
Table 352 Rest of Middle East & Africa: Nasal & Pulmonary Drug Delivery Systems, by Type, 2021–2030 (USD Million)
Table 353 Rest of Middle East & Africa: Nebulizers Market, by Type, 2021–2030 (USD Million)
Table 354 Rest of Middle East & Africa: Empty Inhalers Market, by Type, 2021–2030 (USD Million)
Table 355 Rest of Middle East & Africa: Parenteral Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 356 Rest of Middle East & Africa: Syringes Market, by Type, 2021–2030 (USD Million)
Table 357 Rest of Middle East & Africa: Topical & Transdermal Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 358 Rest of Middle East & Africa: Drop Bottle Drug Delivery Systems Market, by Type, 2021–2030 (USD Million)
Table 359 Rest of Middle East & Africa: Implantable Drug Delivery Devices Market, by Type, 2021–2030 (USD Million)
Table 360 Rest of Middle East & Africa: Drug Delivery Devices Market, by Therapeutic Area, 2021–2030 (USD Million)
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Drug Delivery Devices Market, by Product, 2023 VS. 2030 (USD Million)
Figure 8 Global Drug Delivery Devices Market, by Therapeutic Area, 2023 VS. 2030 (USD Million)
Figure 9 Drug Delivery Devices Market, by Region
Figure 10 Market Dynamics
Figure 11 Global Drug Delivery Devices Market, by Product, 2023 VS. 2030 (USD Million)
Figure 12 Global Drug Delivery Devices Market, by Therapeutic Area, 2023 VS. 2030 (USD Million)
Figure 13 Global Drug Delivery Devices Market, by Region, 2023 VS. 2030 (USD Million)
Figure 14 North America: Drug Delivery Devices Market Snapshot
Figure 15 Europe: Drug Delivery Devices Market Systems Snapshot
Figure 16 Asia-Pacific: Drug Delivery Devices Market Snapshot
Figure 17 Latin America: Drug Delivery Devices Market Snapshot
Figure 18 Middle East & Africa: Drug Delivery Devices Market Snapshot
Figure 19 Key Growth Strategies Adopted by Leading Players, 2020—2023
Figure 20 Global Drug Delivery Devices Market: Competitive Dashboard
Figure 21 Global Drug Delivery Devices Market: Competitive Benchmarking, by Type
Figure 22 Global Drug Delivery Devices Market: Competitive Benchmarking, by Region
Figure 23 Global Drug Delivery Devices Market: Market Share Analysis/ Market Ranking (2022)
Figure 24 Koninklijke Philips N.V.: Financial Overview (2022)
Figure 25 OMRON Corporation: Financial Overview (2022)
Figure 26 Becton, Dickinson & Company: Financial Overview (2022)
Figure 27 Novartis AG: Financial Overview (2022)
Figure 28 Gerresheimer AG: Financial Overview (2022)
Figure 29 West Pharmaceutical Services, Inc.: Financial Overview (2022)
Figure 30 Ypsomed Holding AG: Financial Overview (2022)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Apr-2024
Published Date: Jun-2023
Published Date: Jun-2023
Published Date: Sep-2021
